Brege Laura
SEC insider (Form 3/4/5 filer). CIK 0001365619. Director at Mirum Pharmaceuticals, Inc. (MIRM) and 3 other issuers. 19 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in SAN DIEGO, CA.
Companies Brege Laura has filed insider reports for
- Mirum Pharmaceuticals, Inc. (MIRM): Director
- Edgewise Therapeutics, Inc. (EWTX): Director
- Pacira BioSciences, Inc. (PCRX): Director
- ACADIA PHARMACEUTICALS INC (ACAD): Director
Brege Laura
CIK: 0001365619
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectDeferred Stock Units
2K shares- - Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 10, 2026PCRX
Pacira BioSciences, Inc.
AwardDirect6.4K shares- - Jun 5, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
16.4K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectDirector Stock Options (Right to Buy)
16K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect8.1K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
9.3K shares- - Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect15.5K shares at avg. $74.34$1.2M - Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect17K shares at avg. $15.00$255K - Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect1.5K shares at avg. $75.07$112K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Award Deferred Stock Units | 1,980 | - | - | Direct |
| Jun 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,772 | - | - | Direct |
| Jun 10, 2026 |  PCRX Pacira BioSciences, Inc. | Award | 6,405 | - | $0 | Direct |
| Jun 5, 2026 |  EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 16,377 | - | - | Direct |
| May 29, 2026 |  ACAD ACADIA PHARMACEUTICALS INC | Award Director Stock Options (Right to Buy) | 16,004 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 8,107 | - | $0 | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 9,311 | - | - | Direct |
| Sep 11, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 15,509 | $74.34 | $1,152,939 | Direct |
| Sep 11, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 17,000 | $15.00 | $255,000 | Direct |
| Sep 11, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 1,491 | $75.07 | $111,929 | Direct |
1-10 of 19 transactions